APA (7th ed.) Citation

Igaue, S., Nozaki, R., Utsunomiya, D., Kubo, Y., Kubo, K., Kurita, D., . . . Daiko, H. (2025). Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma. Diseases of the Esophagus, 38(1), 1. https://doi.org/10.1093/dote/doae114

Chicago Style (17th ed.) Citation

Igaue, Shota, et al. "Treatment Strategy Involving Docetaxel Plus Cisplatin and 5-fluorouracil Followed by Conversion Surgery for Locally Advanced Unresectable/borderline Resectable Esophageal Squamous Cell Carcinoma." Diseases of the Esophagus 38, no. 1 (2025): 1. https://doi.org/10.1093/dote/doae114.

MLA (9th ed.) Citation

Igaue, Shota, et al. "Treatment Strategy Involving Docetaxel Plus Cisplatin and 5-fluorouracil Followed by Conversion Surgery for Locally Advanced Unresectable/borderline Resectable Esophageal Squamous Cell Carcinoma." Diseases of the Esophagus, vol. 38, no. 1, 2025, p. 1, https://doi.org/10.1093/dote/doae114.